PureTech Health Revenue and Competitors

Claim your profile

Boston, MA USA

Location

$14.7M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • PureTech Health's estimated annual revenue is currently $19.1M per year.(i)
  • PureTech Health received $50.0M in venture funding in January 2015.
  • PureTech Health's estimated revenue per employee is $155,000
  • PureTech Health's total funding is $14.7M.

Employee Data

  • PureTech Health has 123 Employees.(i)
  • PureTech Health grew their employee count by 26% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.6M4-94%N/AN/A
#2
$2.6M17N/AN/AN/A
#3
$6M39-20%$176.5MN/A
#4
$4.5M29N/AN/AN/A
#5
$2.6M17N/AN/AN/A
#6
N/A145-21%$39.5MN/A
#7
N/A0N/A$9.5MN/A
#8
$15.9M159-39%$135MN/A
#9
$1.7M1157%$20.9MN/A
#10
$2.8M1850%$28.9MN/A

PureTech Health (LSE: PRTC) is an advanced, clinical-stage biopharmaceutical company developing novel medicines around the Brain-Immune-Gut (BIG) Axis. The Company has developed deep insight into the connection between these systems and the resulting role in many chronic diseases, which represent the majority of healthcare spend and have proven resistant to established therapeutic approaches. By harnessing this emerging field of human biology, PureTech Health has developed new categories of medicines with the potential to have great impact on people with serious diseases. PureTech Health is advancing a rich pipeline of innovative therapies across two divisions. Its Affiliates division includes two product candidates that are preparing for potential regulatory approval in the United States and Europe and a number of clinical and pre-clinical programmes. These affiliates have developed ground-breaking platforms and therapeutic candidates in collaboration with some of the world's leading scientific experts. PureTech's Internal division is advancing a pipeline fuelled by recent discoveries in lymphatics and immune cell trafficking to modulate disease in a tissue-specific manner. These programmes build on a new understanding of the trafficking and biodistribution of various immune system components in order to develop targeted therapies for diseases with major unmet needs including cancer and autoimmune and neuroimmune disorders. For more information, visit www.puretechhealth.com or connect with us on Twitter @puretechh.

keywords:Biotechnology,Healthcare,Pharmaceuticals

$14.7M

Total Funding

123

Number of Employees

$19.1M

Revenue (est)

26%

Employee Growth %

N/A

Valuation

N/A

Accelerator

PureTech Health News

2021-07-21 - PureTech Health : Founded Entity Vedanta Biosciences Completes $68 Million Series D Financing

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company, announces that its Founded Entity, Vedanta Biosciences (“Vedanta”), completed a $68 million Series D financing and provided a pipeline update. The Series D financing was led by ...

2021-10-05 - PureTech Health : Founded Entity Vedanta Announces Positive Topline Phase 2 Data for VE303 in High-Risk C. difficile Infection and Exercise of $23.8 Million Option by BARDA

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company, is pleased to note that its Founded Entity, Vedanta Biosciences (“Vedanta”) today announced that its Phase 2 clinical trial of VE303, an orally administered investigational live ...

2021-11-10 - PureTech Health plc PureTech Receives Approximately $100 Million from Sale of a Portion of Founded Entity Shares - Form 6-K

PureTech Health plc PureTech Receives Approximately $100 Million from Sale of a Portion of Founded Entity Shares PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company, today announces that it has sold 750,000 shares of its Founded ...

09/03/2019 - PureTech Announces Board Change

BOSTON--(BUSINESS WIRE)--PureTech Health plc (LSE: PRTC), today announced that Joichi “Joi” Ito, Ph.D., has stepped down from the ...

09/08/2019 - Health Check: How Prudently Does PureTech Health (LON:PRTC) Use Debt?

We note that PureTech Health plc (LON:PRTC) does have debt on its balance sheet. But the real question is whether this debt is making the ...

09/03/2019 - Ito steps down from top job at MIT Media Lab, other high-profile roles

On Monday morning, PureTech Health, a Boston-based company, announced that Ito has stepped down from the board of directors, where he ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$27.1M1233%N/A
#2
$17.8M123N/AN/A
#3
N/A12310%N/A
#4
N/A1233%N/A
#5
$33.2M123-7%N/A

PureTech Health Funding

DateAmountRoundLead InvestorsReference
2014-10-21$55.0MUndisclosedInvesco PerpetualArticle
2015-01-12$50.0MUndisclosedArticle